MetaCap

DBV Technologies S.A. (DBVT) News

NASDAQ: DBVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

9.02-0.40 (-4.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DBVT news summary

We found 10 recent headlines mentioning DBV Technologies S.A. (DBVT): 0 in the past week and 10 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, DBVT is down 4.25% at $9.02. The most recent story, "DBV Technologies présente de nouvelles données issues de l’étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans", was published by GlobeNewswire on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest DBV Technologies S.A. headlines

Compare DBVT